New monthly injection tested for long-term safety in hormone disorder
Disease control
Completed
This study tested the long-term safety of a monthly injection called CAM2029 for adults with acromegaly, a hormonal disorder. 135 patients received the injection under the skin once a month for up to two years. The main goal was to monitor side effects while also checking if the …
Phase: PHASE3 • Sponsor: Camurus AB • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC